Tonix Pharmaceuticals, food and drug administration
Neurizon has filed an Investigational New Drug application with the US FDA for lead drug candidate NUZ-001 to treat ...
Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a ...
(ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce the filing of an Investigational New Drug ...
LONDON - A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the ...
Executives at a local company believe they have a quicker and less expensive path to get their new drug approved.
According to a new study published in Nature Communications, researchers at the Department of Laboratory Medicine, Karolinska ...
Limited announces that the U.S. Food and Drug Administration, FDA, has approved its suitability petition for a new animal drug ...
accepted its New Drug Application (NDA) for investigational candidate paltusotine for the treatment and long-term maintenance therapy of acromegaly in adults. If approved, paltusotine will be the ...
Granules Pharmaceuticals, Inc (GPI) has received approval from the US Food & Drug Administration (USFDA) for its abbreviated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback